Hadile Ounallah Saad

Company: Clexio Biosciences

Job title: Head of Innovation & Early-Stage Pipeline

Seminars:

CLE-905, a potent M1/M4 entering First-in-Human: Similarities to Xanomeline & targeted differentiation from Cobenfy 9:30 am

Target engagement pattern is similar to Xanomeline, confirmed by qEEG Dual M1/M4 agonistRead more

day: Day Two